| Identification | Back Directory | [Name]
(-)-Kinamycin C | [CAS]
35303-08-3 | [Synonyms]
Kinamycin C
(-)-Kinamycin C
1β,3α,4β-Triacetoxy-2β,9-dihydroxy-2-methyl-11-diazo-2,3-dihydro-1H-benzo[b]fluorene-5,10(4H,11H)-dione
(1R)-1β,3α,4β-Triacetoxy-2β,9-dihydroxy-2-methyl-11-diazo-2,3,4,11-tetrahydro-1H-benzo[b]fluorene-5,10-dione
(1R)-1β,3α,4β-Triacetoxy-2β,9-dihydroxy-2-methyl-11-diazo-1,2,3,4,5,10-hexahydro-11H-benzo[b]fluorene-5,10-dione
(1R)-1β,3α,4β-Tris(acetyloxy)-2,3,4,11-tetrahydro-2β,9-dihydroxy-2-methyl-11-diazo-1H-benzo[b]fluorene-5,10-dione | [Molecular Formula]
C24H20N2O10 | [MOL File]
35303-08-3.mol | [Molecular Weight]
496.423 |
| Hazard Information | Back Directory | [Description]
Kinamycin C is a bacterial metabolite that acts as an anticancer agent. | [Uses]
Kinamycin C is a bacterial metabolite containing a diazo group with anticancer activities. Kinamycin C induces a rapid apoptotic response in K562 cells[1]. | [Definition]
ChEBI: Kinamycin C is a kinamycin. | [References]
[1] Brian B Hasinoff, et al. Kinamycins A and C, bacterial metabolites that contain an unusual diazo group, as potential new anticancer agents: antiproliferative and cell cycle effects. Anticancer Drugs. 2006 Aug;17(7):825-37. DOI:10.1097/01.cad.0000224442.78211.27 |
|
|